Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Patent
1995-03-20
1996-12-17
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
A61K 31655
Patent
active
055853676
ABSTRACT:
Compositions useful in methods of treating humans and animals infected with viruses of the retrovirus group contain azoic compounds of the general formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are indentical or different and each represents an atom of hydrogen or an aliphatic or aromatic hydrocarbon radical comprising from 1 to 6 carbon atoms, R.sup.1 and R.sup.2 may be bonded together to form a heterocyclic ring with their adjacent nitrogen atom, and R.sup.3 and R.sup.4 may be bonded together to form a heterocyclic ring with their adjacent nitrogen atom; X.sup.1 and X.sup.2 are indentical or different and each represents an oxygen atom or an NR.sup.5 group, wherein R.sup.5 is a hydrogen atom, an aliphatic or aromatic hydrocarbon radical comprising from 1 to 6 carbon atoms, or a nitro group; and wherein when two NR.sup.5 groups are simultaneously present each R.sup.5 may be indentical to or different from the other.
REFERENCES:
patent: Re24960 (1961-04-01), Urbschat et al.
patent: 3225026 (1965-12-01), Huibers et al.
patent: 3325436 (1967-06-01), Prindle et al.
patent: 3637650 (1972-01-01), Doering
patent: 3684713 (1972-08-01), Piccolini
patent: 5399555 (1995-03-01), Vandevelde et al.
patent: 5468469 (1995-11-01), Aszalos et al.
Oser et al., "Studies of the Safety of Azodicarbonamide as as Flour Maturing Agent"; Toxicology and Applied Pharmacology; vol. 7, pp. 445-472; 1965.
S. S. Block; "Disinfection, Sterilization and Preservation" Lea & Febiger; 3rd Ed.; pp. 172-179; 1983; Philadelphia.
Sies et al.; "Hepatic Calcium Beflux During Cytochrome P-450-Dependent Drug Oxidations at the Endoplasmic Reticulum in Intact Liver"; Proc. Natl. Acad. Sci. USA; vol. 78; No. 6 pp. 3358-3362; Jun. 1981.
Edited by Reynolds; "Disinfectants and Antispetics"; Martindale The Extra Pharmacopoeia; The Pharmaceutical Press; London; 1982, p. 558--Chloroazodin.
Jentsch et al.; "Inhibition of Human Immunodeficiency Virus Type I Reverse Transcriptase by Suramin-Related Compounds"; J. Gen. Virol.; pp. 2183-2192; May 1987.
Kumler; "The Dipole Moments Ultraviolet Spectra of AZO-BIS-(Chloroformamidine) And AZO-BIS-(Nitroformamidine)"; Journal of the American Chemical Society, vol. 75; pp. 3092-3093; 1953.
Resnick et al.; "Stability and Inactivation of HTLV-111/LAV Under Clinical and Laboratory Environments"; JAMA; vol. 255, No. 14; p. 1887-1891; Apr. 11, 1986.
Spire et al.; "Inactivation of Lympha Denopathy Associated Virus By Chemical Disinfectants"; The Lancet; pp. 899-901; Oct. 20, 1984.
Martin et al.; "Disinfection and Inactivation of the Human T Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus" The Journal of Infectious Disease; vol. 152; 400-403; Aug. 1985.
Kosower et al.; "Diamide. A New Reagent for the Intracellular Oxidation of Glutatione to the Disulfide"; Biochemical and Biophysical Research Communication; vol. 37, No. 4, pp. 593-590 1969.
Schmelkes et al.; "N,N'-Dichloroazodicarbonamidine (Azochloramid) An N-Chloro Derivative Oxidant in an . . . " Chemical Society; vol. 56 pp. 1610-1612; 1934.
Hanson, et al.; "Chemical Inactivation of HIV on Surfaces"; BMJ, vol. 298; p. 862-864; Apr. 1, 1984.
Huraux et al.; "Virologie"; Flammarion Medecine Sciences pp. 305; 1985.
Schulhafer et al.; "Acouire Immunodeficiency Syndrome: Molecular Biology and its Therapeutic Intervention (Review)"; In Vivo 3 (2); pp. 61-78; (1989).
Miller et al.; "Genital Mucosal Transmission of Simian Immunode-Ficiency Virus: Animal Model for Heterosexual Transmission of Journal of Virology"; pp. 4277-4284; Oct. 1989.
D'Agay et al.; "Syndrome Immuno Deficitaireacquis"; Doin Editein 2.sup.e edition; pp. 183-184; 1986.
Walker et al. "Inhibition of human immunodeficiency virus . . . " Proc. Nat'l. Acad. Sci. USA, vol. 84 pp. 8320-8124, Nov. 1987.
LePage et al. "posinatal Transmission of HIV from Mother to Child" The Lancet, Aug. 15, 1987 p. 400.
Merck Index p. 132 definition of Azodicarbonamide, 1983.
Hanson, et al.; "Chemical Inactivation of HIV on Surfaces"; BMJ, vol. 298; pp. 862-864; Apr. 1, 1989.
"The Chemistry of Amidines and Imidates", edited by Saul Patal, 1975, John Wiley & Sons, pp. 48-51.
Margery H el ene
Vandevelde Michel
Previsan S.A.
Travers Russell
LandOfFree
Method of treating humans and animals infected with viruses of t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating humans and animals infected with viruses of t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating humans and animals infected with viruses of t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991443